ORAMED PHARMACEUTICALS INC. (ORMP) Gross margin 2016–2025
ORAMED PHARMACEUTICALS INC. (ORMP) gross margin by fiscal year — reported gross profit divided by reported revenue.
0.7%FY2025 · since FY2016: 23.6% → 0.7%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | 0.7% | — |
| FY2019 | 96.7% | -6.8 pp |
| FY2018 | 103.5% | +11.1 pp |
| FY2017 | 92.4% | +68.8 pp |
| FY2016 | 23.6% | — |
Gross margin = reported gross profit ÷ reported revenue for the same fiscal year.
Source: SEC XBRL filings · For reference only · Not investment advice
More ORMP financial trends
ORMP RevenueORMP Net incomeORMP Net marginORMP Gross profitORMP Operating incomeORMP Operating marginORMP Operating cash flowORMP Free cash flowORMP Capital expendituresORMP Return on equityORMP Stock buybacksORMP Dividends paidORMP Total assetsORMP Total liabilitiesORMP Shareholders’ equityORMP overview →